July 2018
Volume 59, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2018
Corneal biochemical analysis and relationship between as needed intravitreous anti-VEGF injections in patients with Angioid Streaks
Author Affiliations & Notes
  • Shotaro Asano
    Ophthalomology, University of Tokyo, Tokyo, Tokyo, Japan
  • Kosuke Nakajima
    Ophthalomology, University of Tokyo, Tokyo, Tokyo, Japan
  • Kana Kure
    Ophthalomology, University of Tokyo, Tokyo, Tokyo, Japan
  • Keiko Azuma
    Ophthalomology, University of Tokyo, Tokyo, Tokyo, Japan
  • Kimiko Shimizu
    Ophthalomology, University of Tokyo, Tokyo, Tokyo, Japan
  • Hiroshi Murata
    Ophthalomology, University of Tokyo, Tokyo, Tokyo, Japan
  • Tatsuya Inoue
    Ophthalomology, University of Tokyo, Tokyo, Tokyo, Japan
  • Ryo Obata
    Ophthalomology, University of Tokyo, Tokyo, Tokyo, Japan
  • Makoto Aihara
    Ophthalomology, University of Tokyo, Tokyo, Tokyo, Japan
  • Ryo Asaoka
    Ophthalomology, University of Tokyo, Tokyo, Tokyo, Japan
  • Footnotes
    Commercial Relationships   Shotaro Asano, None; Kosuke Nakajima, None; Kana Kure, None; Keiko Azuma, None; Kimiko Shimizu, None; Hiroshi Murata, None; Tatsuya Inoue, None; Ryo Obata, None; Makoto Aihara, None; Ryo Asaoka, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science July 2018, Vol.59, 4295. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Shotaro Asano, Kosuke Nakajima, Kana Kure, Keiko Azuma, Kimiko Shimizu, Hiroshi Murata, Tatsuya Inoue, Ryo Obata, Makoto Aihara, Ryo Asaoka; Corneal biochemical analysis and relationship between as needed intravitreous anti-VEGF injections in patients with Angioid Streaks. Invest. Ophthalmol. Vis. Sci. 2018;59(9):4295.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To evaluate the corneal biochemical characteristics measured with Ocular Response Analyzer (ORA) and Corvis ST (CST) in patients with Angioid streaks (AS), and to investigate their effects on the activity of AS though number of intravitreal anti-VEGF injections.

Methods : 29 eyes of 15 patients with AS (68.9 ± 9.6: mean ± standard deviation years old) and 30 eyes of 30 normative subjects (73.6 ± 7.7 years old) were enrolled in this study. The number of the intravitreal anti-VEGF injection to control secondary choroidal neovascularization (CNV) were counted for 5.8 ± 2.5 years. ORA and CST measurements were carried out three times and average values of these ORA and CST parameters were calculated; with ORA: corneal hysteresis (CH) and corneal resistance factor (CRF), and with CST: central corneal thickness: CCT, DA ratio, Integrated Radius, ARTh, SP-A1 and CBI. These parameters were compared between AS and control groups, and then, the relationship between corneal biochemical properties and the number of intravitreal anti-VEGF injection needed per year in eyes with AS was investigated, using the linear mixed model.
All study protocols adhered to the tenets of the Declaration of Helsinki. This retrospective study was approved by the institutional review board of the University of Tokyo Hospital.

Results : Average number of intravitreal anti-VEGF injection in eyes with AS was 1.3 ± 1.5 times per years. There was no significant difference in all of the eight ORA and CST parameters between the AS and control groups, except for significantly thicker [A1] CCT in AS group (p = 0.042). In AS group, lower CH, higher CRF, higher DA ratio were associated with the increased frequency of intravitreal anti-VEGF injection per year.

Conclusions : There was no significant difference between ORA and CST measured corneal biochemical characteristics between AS and control groups. CH, CRF and DA ratio were associated with the activity of AS, as evaluated by the number of intravitreal anti-VEGF injection to control secondary CNV.

This is an abstract that was submitted for the 2018 ARVO Annual Meeting, held in Honolulu, Hawaii, April 29 - May 3, 2018.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×